These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8462075)

  • 1. Is aggressive heparinization necessary for elective PTCA?
    Frierson JH; Dimas AP; Simpfendorfer CC; Pearce G; Miller M; Franco I
    Cathet Cardiovasc Diagn; 1993 Apr; 28(4):279-82. PubMed ID: 8462075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate heparinization during PTCA: assessment using activated clotting times.
    Ogilby JD; Kopelman HA; Klein LW; Agarwal JB
    Cathet Cardiovasc Diagn; 1989 Dec; 18(4):206-9. PubMed ID: 2605621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [-Value of activated blood coagulation time in monitoring anticoagulation during coronary angioplasty-].
    Kunert M; Sorgenicht R; Scheuble L; Ketteler T; Lürken E; Meyer I; Müller A; Emmerich K; Gülker H
    Z Kardiol; 1996 Feb; 85(2):118-24. PubMed ID: 8650981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal heparinization in coronary angioplasty--how much heparin is really warranted?
    Kaluski E; Krakover R; Cotter G; Hendler A; Zyssman I; Milovanov O; Blatt A; Zimmerman E; Goldstein E; Nahman V; Vered Z
    Am J Cardiol; 2000 Apr; 85(8):953-6. PubMed ID: 10760333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
    Pitney MR; Kelly SA; Allan RM; Giles RW; McCredie M; Walsh WF
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural anticoagulation does not reduce angioplasty heparin requirements.
    Blumenthal RS; Wolff MR; Resar JR; Coombs VJ; Brinker JA
    Am Heart J; 1993 May; 125(5 Pt 1):1221-5. PubMed ID: 8480572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty.
    Helft G; Choktron S; Beygui F; Le Feuvre C; Elalamy I; Metzger JP; Vacheron A; Samama MM
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):329-31. PubMed ID: 9829899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of low dose heparin in elective coronary angioplasty.
    Koch KT; Piek JJ; de Winter RJ; David GK; Mulder K; Tijssen JG; Lie KI
    Heart; 1997 Jun; 77(6):517-22. PubMed ID: 9227294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
    Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
    Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Herrmann HC; Laskey WK
    Am Heart J; 1992 Jul; 124(1):1-8. PubMed ID: 1615790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
    Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
    Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin.
    Dougherty KG; Gaos CM; Bush HS; Leachman DR; Ferguson JJ
    Cathet Cardiovasc Diagn; 1992 Aug; 26(4):260-3. PubMed ID: 1394411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence, predisposing factors, acute complications and prognostic significance of intracoronary thrombus formation during PTCA].
    Schächinger V; Kasper W; Wollschläger H; Zeiher AM
    Z Kardiol; 1993 Nov; 82(11):712-20. PubMed ID: 8291293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi.
    Mooney MR; Mooney JF; Goldenberg IF; Almquist AK; Van Tassel RA
    Am J Cardiol; 1990 Feb; 65(7):427-31. PubMed ID: 2305681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser balloon angioplasty combined with local intracoronary heparin therapy: immediate and short-term follow-up results.
    Glazier JJ; Jiang AJ; Crilly RJ; Spears JR
    Am Heart J; 1997 Aug; 134(2 Pt 1):266-73. PubMed ID: 9313607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
    Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin monitoring in the coronary care unit after percutaneous transluminal coronary angioplasty.
    Varah N; Smith J; Baugh RF
    Heart Lung; 1990 May; 19(3):265-70. PubMed ID: 2341265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
    Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of catheter technology and adjuvant medication on acute complications in percutaneous coronary angioplasty.
    Spielberg C; Schnitzer L; Linderer T; Schröder R
    Cathet Cardiovasc Diagn; 1990 Oct; 21(2):72-6. PubMed ID: 2225038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation.
    Lehmann KG; Gonzales E; Tri BD; Vaziri ND
    Am Heart J; 1999 Feb; 137(2):274-83. PubMed ID: 9924161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.